The ESP Congresses are 5-day annual international pathology congresses by the European Society of Pathology and the largest gatherings of pathologists in Europe.
The aim is to provide an up-to-date scientific programme (e.g. keynote lectures, symposia, slide seminars, short courses, discussions) covering all major areas of diagnostic, translational, molecular and investigative pathology. Special emphasis will be put on both the recent discoveries and the reinforcement of close clinicopathological cooperation.
The 38th ECP will be delivered as a hybrid event with both live participation in Stockholm, Sweden and online participation. Speakers and Chairs will participate exclusively on-site.
Here is why you should attend:
- All-in-one delegate fee (no sessions/courses to be paid extra)
- The opportunity to meet pathologists from over 100 countries around the globe at the biggest pathology conference world-wide
- A chance to meet your peers and evaluate research in front of the world’s leading pathology experts
- Outstanding keynote lectures
- Opportunity to interact with world-renowned speakers and chairs
- A world-class platform to exhibit your products and services
- Attractive industry sessions
- Large part of content available on demand after the congress
The core programme is being prepared with a strong input from the ESP Working Groups, ESP-affiliated Societies, Education and Trainee Subcomittees.
Expected educational outcome(s):
- Familiarity with all histological and molecular approaches that are essential, according to current evidence, in the management of diseases.
- Confidence in managing patients (screening, diagnosing, data reporting, and follow-up therapy) with neoplastic and non-neoplastic disorders that are identified, according to the existing evidence, by pathological procedures.
- Identify major pitfalls and possible solutions in the diagnosis of certain clinical situations.
- Discuss and integrate the most up-to date knowledge and recent research findings in the field of human pathology.
- Identify opportunities for scientific collaborations worldwide.
